Reduced Cerebrovascular Reserve Capacity as a Biomarker of Microangiopathy in Alzheimer's Disease and Mild Cognitive Impairment

被引:28
|
作者
Urbanova, Barbora Soukupova [1 ]
Schwabova, Jaroslava Paulasova [1 ]
Magerova, Hana [1 ]
Jansky, Petr [1 ]
Markova, Hana [1 ,2 ]
Vyhnalek, Martin [1 ,2 ]
Laczo, Jan [1 ,2 ]
Hort, Jakub [1 ,2 ]
Tomek, Ales [1 ]
机构
[1] Charles Univ Prague, Motol Univ Hosp, Fac Med 2, Dept Neurol, Prague, Czech Republic
[2] St Annes Univ, Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic
关键词
Alzheimer's disease; breath-holding index; cerebrovascular reserve capacity; microangiopathy; mild cognitive impairment; transcranial color-coded sonography; transcranial Doppler; BLOOD-FLOW-VELOCITY; TRANSCRANIAL DOPPLER ULTRASOUND; BRAIN PERFUSION SPECT; E EPSILON-4 ALLELE; BODY-MASS INDEX; VASOMOTOR REACTIVITY; VASCULAR DEMENTIA; APOLIPOPROTEIN-E; CEREBRAL VASOREACTIVITY; VASODILATORY STIMULUS;
D O I
10.3233/JAD-170815
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Cerebral microangiopathy in Alzheimer's disease (AD) causes chronic hypoperfusion and probably accelerates neurodegenerative changes. Objective: We hypothesize microvascular impairment could be present already in mild cognitive impairment (MCI) and can be revealed using transcranial color-coded sonography (TCCS) and the breath-holding maneuver. Methods: Three groups of subjects (AD in the stage of dementia, MCI, and cognitively normal controls) with detailed neuropsychological testing and low cerebrovascular burden (no history of stroke, no intra- or extracranial artery stenoses, and no severe vascular lesions on brain MRI), underwent a TCCS assessment of peak systolic (PSV), mean flow (MFV), and end diastolic velocities (EDV) and resistance and pulsatility indices (RI, PI) in large intracranial vessels bilaterally. Cerebrovascular reserve capacity was assessed using the breath-holding index (BHI) in middle cerebral artery (MCA) bilaterally. The ultrasound parameters were compared between the groups, correlated with neuropsychological tests, and compared between amnestic and non-amnestic MCI subtypes. Results: Fourteen AD (3 males, 67.9 +/- 11.1 years, MMSE 18.0 +/- 4.6), 24 MCI (13 males, 71.9 +/- 7.3 years, MMSE 28.0 +/- 1.6), and 24 risk factor-matched controls (14 males, 67.8 +/- 6.4 years, MMSE 29.1 +/- 1.2) were enrolled. Significant differences were found between AD and controls in MFV, EDV, RI, PI in right MCA after breath holding, in PSV, MFV, EDV in left MCA after breath holding, and in BHI on the left side. The left BHI correlated positively with verbal memory test. Conclusion: Results show decreased cerebrovascular reserve capacity in AD as a sign of impaired cerebral hemodynamic status without severe underlying atherosclerosis. This can be identified using TCCS and BHI.
引用
收藏
页码:465 / 477
页数:13
相关论文
共 50 条
  • [41] Biomarker potential of heme oxygenase-1 in Alzheimer's disease and mild cognitive impairment
    Schipper, Hyman M.
    BIOMARKERS IN MEDICINE, 2007, 1 (03) : 375 - 385
  • [42] A Novel Grading Biomarker for the Prediction of Conversion From Mild Cognitive Impairment to Alzheimer's Disease
    Tong, Tong
    Gao, Qinquan
    Guerrero, Ricardo
    Ledig, Christian
    Chen, Liang
    Rueckert, Daniel
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2017, 64 (01) : 155 - 165
  • [43] Urine metabolomics phenotyping and urinary biomarker exploratory in mild cognitive impairment and Alzheimer's disease
    Wang, Yuye
    Sun, Yu
    Wang, Yu
    Jia, Shuhong
    Qiao, Yanan
    Zhou, Zhi
    Shao, Wen
    Zhang, Xiangfei
    Guo, Jing
    Song, Xincheng
    Niu, Xiaoqian
    Peng, Dantao
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [44] Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer's disease
    Chen, Yi
    Therriault, Joseph
    Luo, Jing
    Ba, Maowen
    Zhang, Hua
    JOURNAL OF INTEGRATIVE NEUROSCIENCE, 2021, 20 (04) : 861 - 870
  • [45] Perifovea retinal thickness as an ophthalmic biomarker for mild cognitive impairment and early Alzheimer's disease
    Tao, Rui
    Lu, Zhaozeng
    Ding, Ding
    Fu, Shuhao
    Hong, Zhen
    Liang, Xiaoniu
    Zheng, Li
    Xiao, Yiqin
    Zhao, Qianhua
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2019, 11 (01) : 405 - 414
  • [46] Cerebrovascular disease and gait and balance impairment in mild to moderate Alzheimer’s disease
    Marco Inzitari
    M. Gine-Garriga
    B. Martinez
    M. Perez-Fernandez
    E. Barranco-Rubia
    A. Lleo
    A. Salva-Casanovas
    The journal of nutrition, health & aging, 2013, 17 : 45 - 48
  • [47] Cognitive predictors of medical decision-making capacity in mild cognitive impairment and Alzheimer's disease
    Stormoen, Sara
    Almkvist, Ove
    Eriksdotter, Maria
    Sundstrom, Erik
    Tallberg, Ing-Mari
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2014, 29 (12) : 1304 - 1311
  • [48] Lymphocyte aconitase activity is reduced in Alzheimer disease and mild cognitive impairment
    Mecocci, P
    Rinaldi, P
    Serafini, V
    Metastasio, A
    Mariani, E
    Cherubini, A
    Catani, M
    Cecchetti, R
    Senin, U
    Polidori, MC
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S124 - S124
  • [49] Semantic knowledge in mild cognitive impairment and mild Alzheimer's disease
    Adlam, Anna-Lynne R.
    Bozeat, Sasha
    Arnold, Robert
    Watson, Peter
    Hodges, John R.
    CORTEX, 2006, 42 (05) : 675 - 684
  • [50] Cerebrovascular reactivity in Alzheimer's disease signature regions is associated with mild cognitive impairment in adults with hypertension
    Aslanyan, Vahan
    Mack, Wendy J.
    Ortega, Nancy E.
    Nasrallah, Ilya M.
    Pajewski, Nicholas M.
    Williamson, Jeff D.
    Pa, Judy
    ALZHEIMERS & DEMENTIA, 2024, 20 (03) : 1784 - 1796